Consultative Proteomics provides molecular-based medical consults to physicians worldwide who are treating patients with hard-to-treat or recurrent cancers.

One of our goals is to identify drugs that likely will be ineffective against the patient’s tumor, thus reducing treatment costs and lessening toxicity to the patient.